標題: Titlebook: Breast Cancer Metastasis and Drug Resistance; Challenges and Progr Aamir Ahmad Book 2019Latest edition Springer Nature Switzerland AG 2019 [打印本頁] 作者: bile-acids 時間: 2025-3-21 19:15
書目名稱Breast Cancer Metastasis and Drug Resistance影響因子(影響力)
書目名稱Breast Cancer Metastasis and Drug Resistance影響因子(影響力)學(xué)科排名
書目名稱Breast Cancer Metastasis and Drug Resistance網(wǎng)絡(luò)公開度
書目名稱Breast Cancer Metastasis and Drug Resistance網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Breast Cancer Metastasis and Drug Resistance被引頻次
書目名稱Breast Cancer Metastasis and Drug Resistance被引頻次學(xué)科排名
書目名稱Breast Cancer Metastasis and Drug Resistance年度引用
書目名稱Breast Cancer Metastasis and Drug Resistance年度引用學(xué)科排名
書目名稱Breast Cancer Metastasis and Drug Resistance讀者反饋
書目名稱Breast Cancer Metastasis and Drug Resistance讀者反饋學(xué)科排名
作者: CHECK 時間: 2025-3-21 20:41 作者: 水獺 時間: 2025-3-22 01:45
Health and Racial Disparity in Breast Cancer,cts more than one in ten women worldwide. The chance for a female to be diagnosed with breast cancer during her lifetime has significantly increased from 1 in 11 women in 1975 to 1 in 8 women (Altekruse, SEER Cancer Statistics Review. 1975–2007. National Cancer Institute, Bethesda, 2010). This chanc作者: 場所 時間: 2025-3-22 08:16
,Breast Cancer: Current Perspectives on the?Disease Status, has shown that the past and ongoing research has an enormous implication in improving the clinical outcome in breast cancer. This has been attributed to the progress made in the realm of screening, diagnosis and therapeutic strategies engaged in breast cancer management. However, poor prognosis in 作者: 六個才偏離 時間: 2025-3-22 10:28
,Role of Autophagy in Breast Cancer Development and Progression: Opposite Sides of the?Same Coin,s. Although autophagy is mainly accepted as a cell survival mechanism, it also modulates the process known as “type II cell death”. AKT/mTOR pathway is an upstream activator of autophagy and it is tightly regulated by the ATG (autophagy-related genes) signaling cascade. In addition, wide ranging cel作者: irritation 時間: 2025-3-22 13:53
Breast Cancer Heterogeneity in Primary and Metastatic Disease, of relapse and overall survival. Traditional histopathological classification aims to categorise tumours into subgroups to inform clinical management decisions, but the diversity within these subgroups remains considerable. Application of massively parallel sequencing technologies in breast cancer 作者: 原諒 時間: 2025-3-22 19:47
Bone Metastasis of Breast Cancer,ncer patient. Clinically, complications secondary to bone metastasis include pain, pathologic fractures, spinal cord compression, and hypercalcemia of malignancy. Because bone metastasis is extremely common in patients with metastatic breast cancer, clinical management of bone metastases is an impor作者: 分解 時間: 2025-3-23 00:15
Therapeutic Options for Metastatic Breast Cancer,mportant to develop therapies that go beyond those that just provide palliation of symptoms. Currently, there are several types of therapies available to help treat breast cancer including: hormone therapy, immunotherapy, and chemotherapy, with each one depending on both the location of metastases a作者: Osteoarthritis 時間: 2025-3-23 03:40 作者: Phonophobia 時間: 2025-3-23 09:12 作者: anniversary 時間: 2025-3-23 12:49
Non-coding RNAs as Mediators of Tamoxifen Resistance in Breast Cancers,eptor signaling. However, de novo and acquired resistance against tamoxifen is well known. A number of signaling pathways and de-regulated factors have been evaluated to better understand the mechanism(s) of tamoxifen resistance. For past several years, non-coding RNAs have also gained attention as 作者: 分貝 時間: 2025-3-23 16:59
TRAIL Mediated Signaling in Breast Cancer: Awakening Guardian Angel to Induce Apoptosis and Overcomus breakthroughs have been made in unraveling contributory role of signaling pathways in breast cancer development and progression. It is becoming progressively more understandable that deregulation of spatio-temporally controlled pathways underlie development of resistance against different drugs. 作者: 表兩個 時間: 2025-3-23 18:05 作者: excursion 時間: 2025-3-23 22:48
Targeting of JAK-STAT Signaling in Breast Cancer: Therapeutic Strategies to Overcome Drug Resistanc the knowledge gaps associated with proteins encoded by the human genome. Based on the insights gleaned from decades of research, it seems clear that ligands transmit distinct information through specific receptors that is processed into characteristically unique biological outputs. Advances in imag作者: 使習(xí)慣于 時間: 2025-3-24 06:11
Role of mTORC1 and mTORC2 in Breast Cancer: Therapeutic Targeting of mTOR and Its Partners to Overc integrates environmental clues for regulation of cell survival, metabolism and proliferation of the cells. However, overwhelmingly increasing scientific evidence has added a new layer of intricacy to already complicated and versatile signaling pathway of mTOR. Deregulation of spatio-temporally cont作者: Thyroid-Gland 時間: 2025-3-24 08:57 作者: 兩棲動物 時間: 2025-3-24 12:03
,Targeting CSC in a?Most Aggressive Subtype of Breast Cancer TNBC, receptor, progesterone receptor, and human epithelial growth factor receptor 2 in breast tumor tissues. This subtype of breast cancer has the poorest prognosis, compared to other subtypes of breast cancer. TNBC is heterogeneous by showing several different histo-pathological and molecular subtypes 作者: Iniquitous 時間: 2025-3-24 18:10
Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomrtality among women across the globe. Despite having similar subtypes, breast cancer patients present with a spectrum of aggressiveness and responsiveness to therapy due to cancer heterogeneity. Drug resistance and metastasis contribute to therapy failure and cancer recurrence. Research in the past 作者: recession 時間: 2025-3-24 21:25 作者: 橡子 時間: 2025-3-24 23:11 作者: filicide 時間: 2025-3-25 06:13
Incontinence: Definition and Classificationast cancer patients, but the numbers are still too high. While screenings and early diagnoses should still be a point of focus, particularly in developing and poor countries, more efforts are needed to improve the prognosis of patients diagnosed at a later stage.作者: 入會 時間: 2025-3-25 07:36 作者: 跑過 時間: 2025-3-25 12:49
Male-Mediated Developmental Toxicitygnal–transducer complexes formed during JAK-STAT signaling. Pharmacologists and molecular biologists are focusing on the strategies to therapeutically target this pathway to overcome drug resistance associated with breast cancer.作者: 箴言 時間: 2025-3-25 18:43
Alternating Addition Copolymerizations,st recent findings related to therapeutic targeting of mTOR-associated mTORC1 and mTORC2 in breast cancer. We have also comprehensively summarized regulation of mTOR and its partners by microRNAs in breast cancer.作者: GIBE 時間: 2025-3-25 20:18
Charakteristika des Animationsfilms,on of SMURF1 and WWPs by miRNAs in BCa. SMURFS, WWPs and NEDD4 are versatile regulators and represent a fast-growing field in cancer research and better understanding of the underlying mechanisms will be helpful in transition of our knowledge from a segmented view to a more conceptual continuum.作者: seduce 時間: 2025-3-26 03:55 作者: 躲債 時間: 2025-3-26 04:34
Breast Cancer Heterogeneity in Primary and Metastatic Disease,treating metastatic disease. Central to achieving fully personalised clinical management is translating new insights on breast cancer heterogeneity into the clinical setting, to evolve the taxonomy of breast cancer and improve risk stratification.作者: Axillary 時間: 2025-3-26 11:56 作者: Condense 時間: 2025-3-26 14:17
Role of mTORC1 and mTORC2 in Breast Cancer: Therapeutic Targeting of mTOR and Its Partners to Overcst recent findings related to therapeutic targeting of mTOR-associated mTORC1 and mTORC2 in breast cancer. We have also comprehensively summarized regulation of mTOR and its partners by microRNAs in breast cancer.作者: 有害 時間: 2025-3-26 20:03 作者: narcotic 時間: 2025-3-27 00:22 作者: 冥界三河 時間: 2025-3-27 04:36
,Introduction: Thomas Mann’s Dialectics,s in recent years has also shifted to epigenetic and non-coding RNA basis of acquired resistance against trastuzumab. This article provides a succinct discussion on the most recent advances in our understanding of such factors.作者: Ornithologist 時間: 2025-3-27 05:28
Correction to: Male, Failed, Jailed,num- and/or drug-resistant breast tumors and metastases. This chapter provides an overview of the latest developments in the field of platinum-based drugs against advanced and resistant breast cancers since 2013.作者: 最高點 時間: 2025-3-27 12:10
Current Updates on Trastuzumab Resistance in HER2 Overexpressing Breast Cancers,s in recent years has also shifted to epigenetic and non-coding RNA basis of acquired resistance against trastuzumab. This article provides a succinct discussion on the most recent advances in our understanding of such factors.作者: MILK 時間: 2025-3-27 15:57 作者: Addictive 時間: 2025-3-27 19:27
Modern and Contemporary Poetry and Poeticsis the rising rate of breast cancer incidence and mortality among the population of under developed world. In this chapter, an overview of the current practices for the diagnosis and treatment of breast cancer and associated impediments has been provided.作者: 鞠躬 時間: 2025-3-27 23:55
https://doi.org/10.1007/978-94-010-1651-3s well as from evaluation of clinical samples, to showcase the power of non-coding RNAs as mediators of tamoxifen resistance and the predictors of disease relapse. This article puts into perspective the available information on microRNAs and the long non-coding RNAs regarding their ability to tweak resistance vs. sensitivity to tamoxifen.作者: 時代錯誤 時間: 2025-3-28 03:44
,Breast Cancer: Current Perspectives on the?Disease Status,is the rising rate of breast cancer incidence and mortality among the population of under developed world. In this chapter, an overview of the current practices for the diagnosis and treatment of breast cancer and associated impediments has been provided.作者: 錫箔紙 時間: 2025-3-28 06:25 作者: 花束 時間: 2025-3-28 11:26
https://doi.org/10.1007/978-3-030-20301-6bone metastasis; breast cancer statistics; breast cancer stem cells; tamoxifen; triple negative breast c作者: Cardiac 時間: 2025-3-28 15:29
978-3-030-20303-0Springer Nature Switzerland AG 2019作者: 埋葬 時間: 2025-3-28 19:48 作者: 歌曲 時間: 2025-3-29 02:24 作者: d-limonene 時間: 2025-3-29 03:16
Breast Cancer Metastasis and Drug Resistance978-3-030-20301-6Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: 柱廊 時間: 2025-3-29 07:28 作者: 翅膀拍動 時間: 2025-3-29 13:32
https://doi.org/10.1007/978-3-319-19252-9 cancer is an important cause of human suffering and premature mortality among women. In the United States, breast cancer accounts for more cancer deaths in women than any site other than lung cancer. A variety of risk factors for breast cancer have been well-established by epidemiologic studies inc作者: 短程旅游 時間: 2025-3-29 16:54
https://doi.org/10.1057/9780230106802cts more than one in ten women worldwide. The chance for a female to be diagnosed with breast cancer during her lifetime has significantly increased from 1 in 11 women in 1975 to 1 in 8 women (Altekruse, SEER Cancer Statistics Review. 1975–2007. National Cancer Institute, Bethesda, 2010). This chanc作者: interlude 時間: 2025-3-29 23:03
Modern and Contemporary Poetry and Poetics has shown that the past and ongoing research has an enormous implication in improving the clinical outcome in breast cancer. This has been attributed to the progress made in the realm of screening, diagnosis and therapeutic strategies engaged in breast cancer management. However, poor prognosis in 作者: Femish 時間: 2025-3-30 01:59 作者: Expediency 時間: 2025-3-30 06:59
https://doi.org/10.1057/9780230281752 of relapse and overall survival. Traditional histopathological classification aims to categorise tumours into subgroups to inform clinical management decisions, but the diversity within these subgroups remains considerable. Application of massively parallel sequencing technologies in breast cancer 作者: 巨大沒有 時間: 2025-3-30 08:50 作者: modest 時間: 2025-3-30 14:46 作者: Orgasm 時間: 2025-3-30 16:55 作者: Hormones 時間: 2025-3-30 22:57 作者: Flat-Feet 時間: 2025-3-31 02:35
https://doi.org/10.1007/978-94-010-1651-3eptor signaling. However, de novo and acquired resistance against tamoxifen is well known. A number of signaling pathways and de-regulated factors have been evaluated to better understand the mechanism(s) of tamoxifen resistance. For past several years, non-coding RNAs have also gained attention as 作者: Generator 時間: 2025-3-31 05:12 作者: 愛好 時間: 2025-3-31 11:27
Correction to: Male, Failed, Jailed,for patients suffering from advanced stages and metastases, or those who are no longer responding to the clinically established drugs such as cisplatin or carboplatin. New promising therapy regimens and platinum complexes have emerged over the last few years that displayed efficacy in advanced plati作者: neolith 時間: 2025-3-31 17:02
